The heart of the matter Both type 2 diabetes and obesity put you at risk of cardiovascular disease, though we havent known exactly why
For those seeking additional support, the following resources are available: NHS Digital Weight Management Programme (online, free at point of access for eligible adults referral required) Diabetes UK and BEAT Eating Disorders for condition-specific guidance British Dietetic Association (BDA) for finding a registered dietitian If you are struggling to lose weight despite genuine effort, the most important message is this: seek help early, be honest with your healthcare team, and know that effective, evidence-based support is available
The findings provide a powerful counterpoint to the challenge of low medication adherence in real-world settings, where many patients stop taking GLP-1s before they can see the full clinical benefit
SUSTAIN-6, conducted in patients with type 2 diabetes, showed a 26% reduction in major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) with semaglutide compared to placebo